BCAB Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.38%

Insider Buying (Last 12 Months): $162,400.00

Insider Selling (Last 12 Months): $0.00

BioAtla Insider Trading History Chart

BioAtla Share Price & Price History

^$2.58

▲ +0.04 (1.57%)

As of 04/29/2024 01:00 AM ET

Days: 30 | 90 | 365

Charles Payne’s Gift to Stock Investors

From Unstoppable Prosperity | Ad

Right now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.

Watch Insider's Advantage Event Tuesday at 4:00 PM ET

BioAtla Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/26/2023	Sylvia Mcbrinn	Director	Buy	4,000	$2.33	$9,320.00	15,125
12/20/2023	Jay M. Short	CEO	Buy	50,000	$2.14	$107,000.00	1,439,283
12/19/2023	Lawrence Steinman	Director	Buy	20,000	$2.05	$41,000.00	38,459
9/8/2023	Sylvia Mcbrinn	Director	Buy	2,000	$2.54	$5,080.00	11,125
3/29/2023	Jay M. Short	CEO	Buy	40,800	$2.47	$100,776.00	1,412,387
3/28/2023	Christian Vasquez	Insider	Buy	20,000	$2.40	$48,000.00	102,709
12/19/2022	Sylvia Mcbrinn	Director	Buy	3,700	$8.33	$30,821.00	9,125
11/22/2022	Sylvia Mcbrinn	Director	Buy	2,000	$8.27	$16,540.00	5,425
9/12/2022	Sylvia Mcbrinn	Director	Buy	2,000	$8.85	$17,700.00	2,000
8/12/2022	Jay M. Short	CEO	Buy	26,350	$7.84	$206,584.00	1,396,556
6/21/2022	Jay M. Short	CEO	Buy	29,082	$2.79	$81,138.78	1,335,674
6/9/2022	Christian Vasquez	Insider	Buy	10,000	$2.97	$29,700.00	74,525
6/7/2022	Christian Vasquez	Insider	Buy	14,152	$3.04	$43,022.08	38,677
12/1/2021	Christian Vasquez	Insider	Sell	1,011	$23.04	$23,293.44
12/1/2021	Jay M. Short	CEO	Sell	24,321	$23.03	$560,112.63
12/1/2021	Richard A. Waldron	CFO	Sell	7,246	$23.03	$166,875.38
12/1/2021	Scott Andrew Smith	President	Sell	628	$23.03	$14,462.84
11/29/2021	Christian Vasquez	Insider	Sell	642	$23.89	$15,337.38
11/29/2021	Jay M. Short	CEO	Sell	15,435	$23.89	$368,742.15
11/29/2021	Richard A. Waldron	CFO	Sell	4,599	$23.89	$109,870.11
11/29/2021	Scott Andrew Smith	President	Sell	399	$23.89	$9,532.11
11/24/2021	Christian Vasquez	Insider	Sell	750	$24.87	$18,652.50
11/24/2021	Jay M. Short	CEO	Sell	17,022	$24.87	$423,337.14
11/24/2021	Richard A. Waldron	CFO	Sell	3,937	$24.87	$97,913.19
11/24/2021	Scott Andrew Smith	President	Sell	466	$24.87	$11,589.42
11/22/2021	Christian Vasquez	Insider	Sell	691	$26.23	$18,124.93
11/22/2021	Jay M. Short	CEO	Sell	15,675	$26.23	$411,155.25
11/22/2021	Richard A. Waldron	CFO	Sell	3,626	$26.23	$95,109.98
11/22/2021	Scott Andrew Smith	President	Sell	430	$26.23	$11,278.90
11/2/2021	Lawrence Steinman	Director	Sell	450	$30.00	$13,500.00
10/1/2021	Eric Sievers	Insider	Sell	592	$30.39	$17,990.88
10/1/2021	Scott Andrew Smith	President	Sell	2,994	$30.18	$90,358.92
9/15/2021	Lawrence Steinman	Director	Sell	450	$36.82	$16,569.00
8/26/2021	Eric Sievers	Insider	Sell	6,883	$39.59	$272,497.97	93,766
8/26/2021	Scott Andrew Smith	President	Sell	33,244	$40.16	$1,335,079.04	368,568
8/24/2021	Guy Levy	Director	Sell	546,709	$39.65	$21,677,011.85
8/24/2021	Jay M. Short	CEO	Sell	4,533	$41.60	$188,572.80	1,441,508
8/16/2021	Lawrence Steinman	Director	Sell	450	$40.60	$18,270.00
7/15/2021	Lawrence Steinman	Director	Sell	450	$38.29	$17,230.50
6/21/2021	Jay M. Short	CEO	Sell	55,000	$39.13	$2,152,150.00	1,441,508
6/17/2021	Jay M. Short	CEO	Sell	19,269	$39.22	$755,730.18	1,441,508

Have You Seen Elon’s New A.I. Device? (Picture Inside)

From InvestorPlace | Ad

A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...

This strange new device to protect us against that A.I. threat...

SEC Filings (Institutional Ownership Changes) for BioAtla (NASDAQ:BCAB)

77.23% of BioAtla stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioAtla Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/12/2024	PVG Asset Management Corp	65,335	$0.16M	0.8%	N/A	0.136%
2/26/2024	Perceptive Advisors LLC	73,000	$0.18M	0.0%	N/A	0.152%
2/14/2024	Pale Fire Capital SE	48,383	$0.12M	0.0%	+204.6%	0.101%
2/8/2024	Panagora Asset Management Inc.	111,366	$0.27M	0.0%	+110.0%	0.232%
2/7/2024	Formidable Asset Management LLC	154,246	$0.38M	0.1%	-5.3%	0.322%
2/2/2024	Simplex Trading LLC	11,926	$29K	0.0%	-71.3%	0.025%
2/1/2024	SC&H Financial Advisors Inc.	65,519	$0.16M	0.0%	-7.9%	0.137%
1/30/2024	Vontobel Holding Ltd.	706,062	$1.74M	0.0%	-1.3%	1.473%
1/1/2024	Vanguard Group Inc.	2,102,316	$3.57M	0.0%	+0.2%	4.385%
11/15/2023	Sectoral Asset Management Inc.	706,062	$1.20M	0.2%	+26.9%	1.477%
11/15/2023	Adage Capital Partners GP L.L.C.	1,796,148	$3.05M	0.0%	-5.2%	3.757%
11/15/2023	Affinity Asset Advisors LLC	180,000	$0.31M	0.1%	-44.6%	0.377%
11/9/2023	Formidable Asset Management LLC	162,794	$0.28M	0.1%	+79.0%	0.341%
11/9/2023	Deutsche Bank AG	279,122	$0.48M	0.0%	-59.7%	0.584%
11/8/2023	Vivo Capital LLC	534,181	$0.91M	0.1%	-16.2%	1.118%
11/8/2023	Massachusetts Financial Services Co. MA	528,667	$0.90M	0.0%	-30.1%	1.106%
10/31/2023	Panagora Asset Management Inc.	53,030	$90K	0.0%	N/A	0.111%
10/30/2023	SC&H Financial Advisors Inc.	71,125	$0.12M	0.0%	+232.4%	0.149%
10/13/2023	SG Americas Securities LLC	21,963	$37K	0.0%	N/A	0.046%
10/11/2023	Vontobel Holding Ltd.	715,195	$1.22M	0.0%	+26.4%	1.496%
9/21/2023	Barclays PLC	8,827	$27K	0.0%	N/A	0.018%
8/11/2023	Pale Fire Capital SE	15,883	$48K	0.0%	N/A	0.033%
8/11/2023	MYDA Advisors LLC	60,000	$0.18M	0.1%	+9.1%	0.126%
8/11/2023	Sectoral Asset Management Inc.	556,518	$1.67M	0.3%	+2.5%	1.167%
8/8/2023	Wasatch Advisors LP	1,500,934	$4.50M	0.0%	+18.4%	3.149%
8/4/2023	American International Group Inc.	21,290	$64K	0.0%	N/A	0.045%
8/2/2023	Bank of Montreal Can	16,078	$62K	0.0%	N/A	0.034%
7/24/2023	Vontobel Holding Ltd.	565,651	$1.70M	0.0%	+2.4%	1.187%
7/13/2023	Transcend Capital Advisors LLC	49,000	$0.15M	0.0%	N/A	0.103%
6/1/2023	Prelude Capital Management LLC	12,846	$34K	0.0%	-20.6%	0.027%
5/15/2023	Affinity Asset Advisors LLC	325,000	$0.87M	0.3%	+116.7%	0.683%
5/15/2023	MYDA Advisors LLC	55,000	$0.15M	0.1%	N/A	0.116%
5/12/2023	Sectoral Asset Management Inc.	543,009	$1.46M	0.3%	+292.6%	1.141%
5/11/2023	Cornercap Investment Counsel Inc.	61,534	$0.17M	0.0%	+89.0%	0.129%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	48,614	$0.13M	0.0%	N/A	0.102%
5/9/2023	Formidable Asset Management LLC	90,935	$0.24M	0.1%	+162.8%	0.191%
5/3/2023	Jump Financial LLC	46,800	$0.13M	0.0%	N/A	0.098%
5/1/2023	Virtu Financial LLC	10,302	$28K	0.0%	N/A	0.022%
4/12/2023	Vontobel Holding Ltd.	552,142	$1.48M	0.0%	+274.5%	1.160%
2/15/2023	Tang Capital Management LLC	3,124,076	$25.77M	3.7%	+58.8%	8.307%
2/15/2023	Endurant Capital Management LP	136,382	$1.13M	0.5%	N/A	0.363%
2/15/2023	Avidity Partners Management LP	1,260,000	$10.40M	0.2%	N/A	3.350%
2/14/2023	683 Capital Management LLC	18,593	$0.15M	0.0%	N/A	0.049%
2/14/2023	EcoR1 Capital LLC	1,124,439	$9.28M	0.3%	N/A	2.990%
2/13/2023	Vivo Capital LLC	637,181	$5.26M	0.6%	N/A	1.694%
2/10/2023	Opaleye Management Inc.	261,800	$2.16M	0.8%	N/A	0.696%
2/10/2023	Sectoral Asset Management Inc.	138,294	$1.14M	0.2%	N/A	0.368%
2/9/2023	Citigroup Inc.	40,876	$0.34M	0.0%	+1,611.7%	0.109%
2/7/2023	Fox Run Management L.L.C.	25,490	$0.21M	0.1%	N/A	0.068%
2/7/2023	Commonwealth Equity Services LLC	20,000	$0.17M	0.0%	N/A	0.053%
2/7/2023	Formidable Asset Management LLC	34,607	$0.29M	0.1%	-16.4%	0.092%
2/7/2023	Bleakley Financial Group LLC	10,407	$86K	0.0%	N/A	0.028%
11/15/2022	Tang Capital Management LLC	1,967,051	$15.15M	1.9%	-41.7%	5.231%
11/15/2022	Eventide Asset Management LLC	795,000	$6.12M	0.1%	N/A	2.114%
11/15/2022	Formidable Asset Management LLC	41,420	$0.32M	0.1%	-42.5%	0.110%
11/14/2022	Cormorant Asset Management LP	2,181,115	$16.80M	1.2%	+7.0%	5.800%
11/14/2022	Point72 Asset Management L.P.	764,700	$5.89M	0.0%	N/A	2.033%
11/14/2022	PDT Partners LLC	24,496	$0.19M	0.0%	-76.0%	0.065%
11/14/2022	Renaissance Technologies LLC	565,600	$4.36M	0.0%	-27.5%	1.504%
11/14/2022	Altium Capital Management LP	553,000	$4.26M	1.6%	N/A	1.470%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	860,200	$6.62M	0.0%	+101.2%	2.287%
11/14/2022	UBS Oconnor LLC	112,000	$0.86M	0.0%	N/A	0.298%
11/9/2022	Massachusetts Financial Services Co. MA	531,787	$4.10M	0.0%	+7.3%	1.421%
11/2/2022	DekaBank Deutsche Girozentrale	12,500	$95K	0.0%	N/A	0.033%
10/28/2022	Silverarc Capital Management LLC	200,422	$1.54M	0.5%	N/A	0.536%
10/25/2022	Denali Advisors LLC	7,300	$56K	0.0%	N/A	0.020%
10/24/2022	Twin Lakes Capital Management LLC	9,000	$69K	0.1%	N/A	0.024%
8/16/2022	Formidable Asset Management LLC	72,087	$0.21M	0.0%	N/A	0.193%
8/15/2022	Laurion Capital Management LP	292,600	$0.83M	0.0%	N/A	0.782%
8/13/2022	Massachusetts Financial Services Co. MA	495,768	$1.41M	0.0%	-0.7%	1.325%
8/13/2022	Rinkey Investments	23,410	$76K	0.1%	N/A	0.063%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	427,500	$1.22M	0.0%	N/A	1.143%
7/29/2022	Russell Investments Group Ltd.	66,500	$0.19M	0.0%	+16.3%	0.178%
7/19/2022	Commonwealth Equity Services LLC	14,000	$39K	0.0%	N/A	0.037%
7/19/2022	Sawtooth Solutions LLC	10,045	$29K	0.0%	N/A	0.027%
7/13/2022	Private Advisor Group LLC	10,290	$29K	0.0%	N/A	0.028%
6/7/2022	Teachers Retirement System of The State of Kentucky	5,019	$25K	0.0%	-64.2%	0.013%
5/27/2022	Walleye Capital LLC	170,326	$0.85M	0.0%	N/A	0.455%
5/12/2022	Twin Lakes Capital Management LLC	9,000	$45K	0.0%	N/A	0.024%
5/11/2022	Massachusetts Financial Services Co. MA	499,491	$2.50M	0.0%	+2.8%	1.338%
5/11/2022	GSA Capital Partners LLP	32,807	$0.16M	0.0%	N/A	0.088%
5/9/2022	Qube Research & Technologies Ltd	17,936	$90K	0.0%	-48.8%	0.048%
5/6/2022	Los Angeles Capital Management LLC	66,620	$0.33M	0.0%	N/A	0.179%
5/5/2022	Russell Investments Group Ltd.	57,200	$0.29M	0.0%	N/A	0.153%
4/29/2022	SG Americas Securities LLC	13,524	$68K	0.0%	+165.0%	0.036%
4/29/2022	Nisa Investment Advisors LLC	33,400	$0.17M	0.0%	N/A	0.089%
4/21/2022	Virginia Retirement Systems ET AL	14,200	$71K	0.0%	N/A	0.038%
4/12/2022	Eidelman Virant Capital	10,000	$50K	0.0%	N/A	0.027%
2/19/2022	Woodline Partners LP	446,141	$8.76M	0.1%	+196.1%	1.211%
2/14/2022	Virtus ETF Advisers LLC	7,912	$0.16M	0.1%	+48.5%	0.021%
2/14/2022	Deerfield Management Company L.P. Series C	289,002	$5.67M	0.1%	-37.8%	0.785%
2/14/2022	Perceptive Advisors LLC	661,200	$12.98M	0.2%	-22.2%	1.795%
2/11/2022	Ensign Peak Advisors Inc	5,160	$0.10M	0.0%	N/A	0.014%
2/10/2022	Qube Research & Technologies Ltd	35,019	$0.69M	0.0%	N/A	0.095%
2/10/2022	Rafferty Asset Management LLC	83,078	$1.63M	0.0%	+108.7%	0.226%
2/10/2022	Citigroup Inc.	70,594	$1.39M	0.0%	+162.4%	0.192%
2/10/2022	Massachusetts Financial Services Co. MA	485,690	$9.53M	0.0%	-0.7%	1.319%
2/8/2022	Northern Trust Corp	180,048	$3.54M	0.0%	+2.2%	0.489%
2/2/2022	New York State Common Retirement Fund	10,332	$0.20M	0.0%	+21.1%	0.028%
2/1/2022	Qube Research & Technologies Ltd	35,019	$0.69M	0.0%	N/A	0.095%

Data available starting January 2016

BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC), which is in Phase II clinical trial for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC that is in Phase II clinical trial for the treatment of melanoma and squamous cell cancer of the head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody, which is in Phase II clinical trial for treating melanoma, carcinomas, and NSCLC; and BA3182, a bispecific candidate that is in Phase 1 study for the treatment of adenocarcinomas, as well as BA3361, which is in preclinical studies for treating multiple tumor types. The company was founded in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $2.58

$2.52

$2.69

50 Day Range

MA: $2.80

$2.11

$3.92

52 Week Range

Now: $2.58

$1.24

$4.07

Volume

478,491 shs

Average Volume

505,699 shs

Market Capitalization

$124.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.07

Who are the company insiders with the largest holdings of BioAtla?: BioAtla's top insider shareholders include:
Jay M Phd Short (CEO)
Christian Vasquez (Insider)
Lawrence Steinman (Director)
Sylvia Mcbrinn (Director)
Learn More about top insider investors at BioAtla.